CD30 is a transmembrane receptor in the tumor necrosis factor (TNF) receptor family, which is universally expressed in classic Hodgkin lymphoma and ALCL, as well as most other PTCL subtypes, with variable expression in approximately 55–60% of cases [19,20]. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.